KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeGross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Evolent Health (EVH) Operating Expenses (2016 - 2025)

Historic Operating Expenses for Evolent Health (EVH) over the last 11 years, with Q3 2025 value amounting to $478.6 million.

  • Evolent Health's Operating Expenses fell 2493.8% to $478.6 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year decrease of 1726.58%. This contributed to the annual value of $2.6 billion for FY2024, which is 2752.28% up from last year.
  • Evolent Health's Operating Expenses amounted to $478.6 million in Q3 2025, which was down 2493.8% from $445.5 million recorded in Q2 2025.
  • Evolent Health's 5-year Operating Expenses high stood at $665.1 million for Q4 2024, and its period low was $229.1 million during Q3 2021.
  • Moreover, its 5-year median value for Operating Expenses was $445.5 million (2025), whereas its average is $438.9 million.
  • As far as peak fluctuations go, Evolent Health's Operating Expenses plummeted by 4815.76% in 2021, and later surged by 5574.21% in 2023.
  • Evolent Health's Operating Expenses (Quarter) stood at $260.6 million in 2021, then surged by 47.49% to $384.3 million in 2022, then soared by 50.24% to $577.4 million in 2023, then increased by 15.19% to $665.1 million in 2024, then decreased by 28.04% to $478.6 million in 2025.
  • Its Operating Expenses stands at $478.6 million for Q3 2025, versus $445.5 million for Q2 2025 and $485.3 million for Q1 2025.